CLINICAL_TRIALS
trial_result
· 2026-02-20
Clinical Trial Update: Atezolizumab for Idiopathic Pulmonary Fibrosis [Phase 1]
Summary
A Phase 1 clinical trial evaluating atezolizumab for idiopathic pulmonary fibrosis is ongoing but not currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cedars-Sinai Medical Center | Conditions: Idiopathic Pulmonary Fibrosis | Phase 1 | Status: ACTIVE_NOT_RECRUITING